Jilani, Iman <br/><br/>
Differences in CD33 intensity between various myeloid neoplasms.  [electronic resource] 

 -  American journal of clinical pathology  Oct 2002 
 - 560-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0002-9173 
<br/><br/><label>Standard No.: </label>10.1309/1WMW-CMXX-4WN4-T55U  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminoglycosides<br/>Anti-Bacterial Agents--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antigens, CD--analysis<br/>Antigens, Differentiation, Myelomonocytic--analysis<br/>Antineoplastic Agents--therapeutic use<br/>Bone Marrow Cells--immunology<br/>Flow Cytometry<br/>Gemtuzumab<br/>Humans<br/>Immunophenotyping<br/>Immunotoxins<br/>Leukemia--drug therapy<br/>Middle Aged<br/>Myelodysplastic Syndromes--drug therapy<br/>Prospective Studies<br/>Reproducibility of Results<br/>Sialic Acid Binding Ig-like Lectin 3<br/>Single-Blind Method<br/>Survival Analysis<br/>Survival Rate<br/>Treatment Outcome